Europe Generic Drug Market to Reach US$ 89.1 Billion by 2028, Impelled by Increasing Prevalence of Chronic Diseases

February 21, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Europe Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028," the Europe generic drug market reached a value of US$ 56.7 Billion in 2022. A generic drug is a medication produced to be the same as an already marketed brand-name drug in safety, strength, dosage form, administration route, quality, performance features, and intended use. It works similarly and provides the same clinical advantage as the brand-name medicine. It uses the same active ingredients as brand-name medicines. It may have minor differences from the brand-name product, such as color or different inactive ingredients. It is usually much less expensive than brand-name drugs since the drug producer does not have to duplicate the original clinical trials for checking the effectiveness and safety of the medicine, which reduces the overall cost of introducing the drug to the market.

Europe Generic Drug Market Trends:

The market in Europe is primarily driven by the increasing prevalence of chronic diseases, diabetes and cardiovascular diseases. In line with this, the rising geriatric population and the growing healthcare expenditure are significantly contributing to the market growth. Furthermore, a large number of patent-expired branded drugs and the escalating numbers of clinical trials are positively influencing the market. Apart from this, heavy investments in extensive research and development activities and advancements in drug formulation, such as fixed-dose combination and cost-effective treatment, are expected to augment the market expansion. Moreover, numerous government reimbursement programs have favored lower-cost options, thus accelerating the growth of the generic drug market. Besides, the rapid application of robotic process automation is creating a positive outlook for the market. Additionally, new companies are entering into generic drug manufacturing to capture a significant market share. As a result, they are offering cost-effective and efficient generic versions of branded drugs, thereby supporting the market growth. On account of the factors above, the market is anticipated to reach a value of US$ 89.1 Billion by 2028, exhibiting a CAGR of 7.6% during 2023-2028. 

Market Summary:

  • On the basis of the segment, the market has been categorized into unbranded and branded generics.
  • Based on the therapy area, the market has been classified into central nervous system, cardiovascular, dermatology, genitourinary/hormonal, respiratory, rheumatology, diabetes, oncology, and others.
  • Based on the drug delivery, the market has been segmented into oral, injectables, dermal/topical, and inhalers.
  • Based on the distribution channel, the market has been categorized into retail and hospital.
  • On the basis of the country, the market has been divided into Germany, France, the United Kingdom, Italy, Spain, and others.  
  • The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

Report Scope:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Billion
Segment Coverage Segment, Therapy Area, Drug Delivery, Distribution Channel, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

30 N A
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Europe Generic Drug Market to Reach US$ 89.1 Billion by 2028, Impelled by Increasing Prevalence of Chronic Diseases
Purchase options Year End sale

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-713-2163


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More